Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina M Allen

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Hepatology Communications|May 7, 2025
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United StatesJeffrey V Lazarus, Trenton M White, Alina M Allen, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
The Lancet Regional Health. Europe|July 17, 2025
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitisJeffrey V Lazarus, Paul N Brennan, Henry E Mark, et al.
Radiology|April 1, 2025
Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease ProgressionHao Wu, Zheng Zhu, Jiahui Li, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Hepatology Communications|February 7, 2020
Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric SurgeryAlina M Allen, Vijay H Shah, Terry M Therneau, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomesJoseph C Ahn, Puru Rattan, Patrick Starlinger, et al.
Hepatology (Baltimore, Md.)|December 25, 2018
The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric SurgeryAlina M Allen, Vijay H Shah, Terry M Therneau, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Hepatology Communications|May 7, 2025
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United StatesJeffrey V Lazarus, Trenton M White, Alina M Allen, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
The Lancet Regional Health. Europe|July 17, 2025
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitisJeffrey V Lazarus, Paul N Brennan, Henry E Mark, et al.
Radiology|April 1, 2025
Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease ProgressionHao Wu, Zheng Zhu, Jiahui Li, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Hepatology Communications|February 7, 2020
Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric SurgeryAlina M Allen, Vijay H Shah, Terry M Therneau, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomesJoseph C Ahn, Puru Rattan, Patrick Starlinger, et al.
Hepatology (Baltimore, Md.)|December 25, 2018
The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric SurgeryAlina M Allen, Vijay H Shah, Terry M Therneau, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Pageof 12